The carbohydrate-deficient transferrin as a marker of chronic alcohol consumption and assessment of its usefulness in patients with cardiovascular diseases

The carbohydrate-deficient transferrin as a marker of chronic alcohol consumption and assessment of its usefulness in patients with cardiovascular diseases – a pilot study

Published:2023-01-01 Issue:1 Volume:77 Page:91-98
ISSN:1732-2693
Container-title:Postępy Higieny i Medycyny Doświadczalnej
language:en
Short-container-title:

Author:

Waś Joanna Dominika¹^ORCID,Niedolistek Magdalena¹,Sokołowska Dorota¹,Wiśniewska Joanna²,Zieliński Tomasz²^ORCID,Mierzyńska Anna³,Rabczenko Daniel⁴,Orzechowska Beata⁵^ORCID,Franz Dominika⁵,Augustynowicz-Kopeć Ewa⁶^ORCID,Lutyńska Anna¹^ORCID

Affiliation:

1. 1 National Institute of Cardiology - State Research Institute , Warsaw , Poland

2. 2 Department of Heart Failure and Transplantation , National Institute of Cardiology – State Research Institute , Warsaw , Poland

3. 3 Department of Rehabilitation, Medical Centre of Postgraduate Education , Gruca Orthopaedic and Trauma Teaching Hospital , Otwock , Poland

4. 4 Department-Center for Monitoring and Analyses of Population Health Status , National Institute of Public Health – National, Institute of Hygiene , Warsaw , Poland

5. 5 Laboratory of Virology , Department of Immunology of Infectious, Hirszfeld Institute of Immunology and Experimental Therapy , Wroclaw , Poland

6. 6 Department of Microbiology National Reference Laboratory for Mycobacteria , Institute of Tuberculosis and Lung Diseases , Warsaw , Poland

Abstract

Abstract Introduction Cardiovascular diseases (CVDs) are the leading cause of death in the world. The dose of 60 g of alcohol / day has been estimated to significantly increase the risk of developing high blood pressure, arrhythmias, hemorrhagic stroke, and cardiomyopathy. The aim of the study was to evaluate the diagnostic value of CDT when compared with gammaglutamyltransferase (GGT), alkaline phosphatase (ALP), N-terminal fragment brain natriuretic peptide (NT pro-BNP) and troponin T biomarkers in patients with heart failure. Materials and Methods The study was conducted on 59 patients with advanced heart failure with reduced ejection fraction (EF<40%). CDT serum levels were measured using CDT kit, Chromsystems Instruments & Chemicals GmbH, Germany and were expressed as a percentage of total transferrin using high-performance liquid chromatography (HPLC). Results Nineteen patients (n = 19) expressed a normal level of carbohydrate deficiency transferrin <1.2% of the total transferrin found in plasma. The results are obtained from 34 patients (n = 34) were within the range doubtful for the test (1.2–2.5%). In 6 Patients (n = 6) the results of more than 2.5% of CDT content were observed, which could indicate chronic alcohol consumption. Conclusions No statistically significant correlations between CDT and troponin T or NT pro-BNP were identified.

Publisher

Walter de Gruyter GmbH

Subject

Infectious Diseases,Microbiology (medical)

Link

https://www.sciendo.com/pdf/10.2478/ahem-2023-0010

Reference32 articles.

1. O’Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, Rao-Melacini P, Zhang X, Pais P, Agapay S, et al. INTERSTROKE investigators. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016; 388: 761–775.

2. World Health Organization. 2018. Global status report on alcohol and health 2018.

3. Brotman DJ, Golden SH, Wittstein IS. The cardiovascular toll of stress. Lancet. 2007; 370: 1089–1100.

4. Mykletun A, Bjerkeset O, Dewey M, Prince M, Overland S, Stewart R. Anxiety, depression, and cause-specific mortality: the HUNT study. Psychosom Med. 2007; 69: 323–331.

5. Rosengren A, Tibblin G, Wilhelmsen L. Self-perceived psychological stress and incidence of coronary artery disease in middle-aged men. J Am Cardiol. 1991; 68: 1171–1175.